| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: present invention refers to orthopaedics and represents an intra-articular formulation for osteoarthritis, containing glycine, proline, lysine, leucine and a viscosity-controlling polymer.EFFECT: implementing the invention provides extending the range of products for treating osteoarthritis, reducing severity and pain syndrome, as well as increasing an average cartilage thickness.7 cl, 3 tbl |
